3rd Quarter - Report

AMERICAN ASSOCIATION FOR HOMECARE for AMERICAN ASSOCIATION FOR HOMECARE

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Tariff (miscellaneous tariff bills) TAR

Issues related to tariffs on medical devices.

LobbyistCovered position, as disclosed
THOMAS RYAN —
JAY WITTER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, vents, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration; Ensuring Access to Quality Complex Rehabilitation Technology Act (H.R. 2408); Legislation to amend title XVIII of the Social Security Act to provide for the non-application of Medicare competitive acquisition rates to complex rehabilitative wheelchairs and accessories (H.R. 2293/S. 1223/ H.R. 3429); Issues related to reimbursement cuts in noncompetitive bidding areas and O2 Budget Neutrality; H.R. 2771 - Protecting Home Oxygen and Medical Equipment Act of 2019; 21st Century Cures Act (Public Law 114-255), competitive bidding issues; DME issues in the FY2020 President's Budget and CMS ESRD/DMEPOS proposed and final rules; H.R. 2508 - Better Respiration through Expanding Access to Tele-Health Act (BREATHE Act); H.R. 4945 - Safeguarding Medicare Access to Respiratory Therapy Act of 2019; H.R. 1865 - Further Consolidated Appropriations Act, 2020 (Public Law 116-94); H.R. 748 - CARES Act (Public Law 116-136); H.R. 6201 - Family First Coronavirus Response Act (Public Law 116-127); and H.R. 8158 - To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.

LobbyistCovered position, as disclosed
KIM BRASON —
ASHLEY PLAUCHE —
THOMAS RYAN —
MINA UEHARA —
JAY WITTER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2408 (116th), H.R. 748 (116th), H.R. 6201 (116th), H.R. 1865 (116th), H.R. 2771 (116th), H.R. 8158 (116th), H.R. 2293 (116th), H.R. 4945 (116th), S. 1223 (116th), H.R. 3429 (116th), H.R. 2508 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.